Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Diagnostics Firm CEOs
GEN recently published a list of the top 10 highest-paid CEOs of diagnostics companies. One thing we noticed while compiling the list was that diagnostics CEOs generally don’t get paid as much as their drug discovery and tools/tech counterparts. What are your thoughts on what these company leaders are paid?